Evidence map›Paper›PMID 33387518›Full record

ArticleGastroenterology2021

Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19.

Meredith M Pearson, Ajit P Limaye, Scott W Biggins

Abstract readEditorialComment
In one paragraph

Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.Transplant international : official journal of the European Society for Organ Transplantation · 2021
    Review
  7. Liver transplantation during global COVID-19 pandemic.World journal of clinical cases · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Meredith M PearsonDivision of Gastroenterology and HepatologyLiver Care Line, University of Washington Medical Center and, Center for Liver Investigation Fostering discovEry (C-LIFE), University of Washington, Seattle, Washington.
Ajit P LimayeDivision of Infectious Disease, Department of Surgery, Division of Transplantation, University of Washington, Seattle, Washington.
Scott W BigginsDivision of Gastroenterology and Hepatology, Liver Care Line, University of Washington Medical Center and, Center for Liver Investigation Fostering discovEry (C-LIFE), University of Washington, Seattle, Washington. Electronic address: bigginss@medicine.washington.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Liver TransplantationHumansImmunosuppressive AgentsSARS-CoV-2TacrolimusImmunosuppressive AgentsTacrolimus

Identifiers

PMID33387518
PMCPMC7836612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.